baber/WOPTO huggingface dataset:
Patent MX-2022003068-A (MX)
Title: Methods of blocking asfv infection through interruption of cellular receptors.
Inventor: MALCOLM THOMAS
IPC: A61K39/12
Filed: 2020-09-16
Abstract: A method of preventing and treating bacterial or viral infections or cancer in animals, by inhibiting the viral entry protein-to-cellular receptor interaction and preventing and treating bacterial or viral infections or cancer in the animal. A method of treating a viral infection in an individual with a virus that is both lysogenic and lytic, by administering a viral antigen that targets protein on an outer membrane of a lysogenic phase of the virus, administering a viral antigen that targets protein on a capsid of a lytic phase of the virus, and treating the viral infection. A composition for treating a viral infection in an individual with a virus that is both lysogenic and lytic. A method of finding antibodies for treating a viral infection in an individual with a virus that is both lysogenic and lytic.
Patent MX-2022005017-A (MX)
Title: Battery temperature based tool power reduction.
Inventor: FELDKAMP JONATHAN R
IPC: H02J7/04
Filed: 2022-04-26
Abstract: power tool system including a battery pack and a power tool. The power tool includes a power tool housing, a drive unit located within the housing, and a power tool controller located within the housing. The power tool controller is configured to receive a signal from the battery pack (for example, a battery pack controller), the signal indicative of a temperature (for example, a temperature of the battery pack); determine whether the temperature is between a lower temperature threshold and an upper temperature threshold; and limit a power to a drive unit if the temperature is between the lower temperature threshold and the upper temperature threshold.
Patent MX-2022005847-A (MX)
Title: A blocked polyisocyanate crosslinking agent, its preparation method and a coating composition comprising the same.
Inventor: ZHOU SHENGZHONG
IPC: C08G18/67
Filed: 2020-11-09
Abstract: This invention provides a blocked polyisocyanate crosslinking agent obtained from reactions of components comprising a). at least one polyisocyanate selected from aliphatic polyisocyanate, cycloaliphatic polyisocyanate and polyisocyanate-functional polymer and b). at least one beta-diketone. This invention also provides a method of preparing a blocked polyisocyanate crosslinking agent as well as coating compositions comprising the invented blocked polyisocyanate crosslinking agent.
Patent MX-2022006138-A (MX)
Title: Method for extracting active components from plants and devices for such purpose.
Inventor: DIAZ MERCHAN CRISTIAN CAMILO
IPC: C11B9/02
Filed: 2020-11-18
Abstract: The present invention relates to a method and apparatus for extracting active components from a plant material by means of â¢ Introducing the material containing the active components in an extraction chamber â¢ Introducing a hydrofluorocarbonated compound in a tank at a pressure between 482.6 kPa and 1,447.9 kPa (70 psi to 210 psi) â¢ Introducing ethanol in a receptacle â¢ Mixing the hydrofluorocarbonated compound with ethanol â¢ Allowing the mixture to reach the plant material â¢ Allowing the mixture enriched with ethanol and the hydrofluorocarbated compound to flow out of the extraction chamber and into a tank â¢ Allowing the ethanol to evaporate and become separated from the residual mixture slower than the hydrofluorocarbonated compound â¢ Optionally, the hydrofluorocarbonated compound is recovered by condensing and returning it to the pressurised tank â¢ Optionally, the ethanol is recovered by condensing and returning it to the mixing receptacle.
Patent MX-2022008695-A (MX)
Title: Method and apparatus for compressing and decompressing a higher order ambisonics representation for a sound field.
Inventor: BOEHM JOHANNES
IPC: G10L19/008
Filed: 2015-06-10
Abstract: The invention improves HOA sound field representation compression. The HOA representation is analysed for the presence of dominant sound sources and their directions are estimated. Then the HOA representation is decomposed into a number of dominant directional signals and a residual component. This residual component is transformed into the discrete spatial domain in order to obtain general plane wave functions at uniform sampling directions, which are predicted from the dominant directional signals. Finally, the prediction error is transformed back to the HOA domain and represents the residual ambient HOA component for which an order reduction is performed, followed by perceptual encoding of the dominant directional signals and the residual component.
Patent MX-2022010361-A (MX)
Title: Composition of dietary and nutritional supplements to increase the fertile potential in men.
Inventor: CHARLIER KURI CHANTAL
IPC: A61K36/82
Filed: 2022-08-22
Abstract: The present invention relates to fertility-enhancing dietary and nutritional supplement compositions for human male infertility therapy and methods employing said compositions. It comprises Acetyl-L Carnitine 10%, Folic Acid 0.02%, Coenzyme Q 10 3%, L- Carnitine 20%, L- Arginine 5%, Maca (Lepidium Peruvianum) 15%, Selenium 0.002%, Zinc Sulfate 0.5%, Green Tea (Camellia sinensis) 2%, Vitamin B12 (Cyanocobalamin) 0.01%, Vitamin B6 (Pyridoxine) 2.5%, Vitamin C (Ascorbic Acid) 20%, Vitamin E (Tocopherols) 10%, Fructose 11%, Lemon Flavor 1.165%.
Patent MX-2022010938-A (MX)
Title: Iodine compounds for treating respiratory pathogens.
Inventor: FARB MARK DANIEL
IPC: A61K9/00
Filed: 2021-03-23
Abstract: Provided herein are compositions, methods, uses, and articles of manufacture for iodine treatment on mucosal membranes, and treatment of respiratory pathogens in this wayâ<i>e.g</i>., by inhalation and combined with the evaporation of steam. In certain embodiments, iodine treatment encompasses administration of compounds that release molecular iodine and/or physiologically active iodine-containing compounds.
Patent MX-2022012759-A (MX)
Title: Topic segmentation of image-derived text.
Inventor: ANDERSON CAROL MYRICK
IPC: G06F16/35
Filed: 2021-04-12
Abstract: Described herein are systems, methods, and other techniques for segmenting an input text. A set of tokens are extracted from the input text. Token representations are computed for the set of tokens. The token representations are provided to a machine learning model that generates a set of label predictions corresponding to the set of tokens. The machine learning model was previously trained to generate label predictions in response to being provided input token representations. Each of the set of label predictions indicates a position of a particular token of the set of tokens with respect to a particular segment. One or more segments within the input text are determined based on the set of label predictions.
Patent MX-2022012952-A (MX)
Title: Crystalline ret inhibitor.
Inventor: SELBO JON GORDON
IPC: A61P35/00
Filed: 2021-04-09
Abstract: Provided herein is a crystalline form of selpercatinib useful in the treatment and prevention of diseases which can be treated with a RET kinase inhibitor, including RET-associated diseases and disorders, and methods of making this crystalline form.
Patent MX-2022013534-A (MX)
Title: Hemostatic devices.
Inventor: LO DENNY
IPC: A61L15/42
Filed: 2014-12-17
Abstract: Hemostatic devices for promoting blood clotting can include a substrate (e.g., gauze, textile, sponge, sponge matrix, one or more fibers, etc.), a hemostatic material disposed thereon such as kaolin clay, and a binder material such as crosslinked calcium alginate with a high guluronate monomer molar percentage disposed on the substrate to substantially retain the hemostatic material material. When the device is used to treat a bleeding wound, at least a portion of the clay material comes into contact with blood to accelerate clotting. Moreover, when exposed to blood, the binder has low solubility and retains a majority of the clay material on the gauze. A bandage that can be applied to a bleeding wound to promote blood clotting includes a flexible substrate and a gauze substrate mounted thereon.
Patent MX-2022014110-A (MX)
Title: Sting agonist combination treatments with immune checkpoint inhibitors.
Inventor: CHEN ZHIJIAN
IPC: A61K31/352
Filed: 2021-05-17
Abstract: The disclosure provides, among other things, methods and uses for treating a disease or disorder, particularly a cancer, in a patient, comprising conjointly administering a CTLA4 inhibitor (e.g., an anti-CTLA4 antibody) and a STING agonist to the patient, wherein the CTLA4 inhibitor is administered intratumorally to the patient. The STING agonist can be administered intratumorally, orally or systemically (e.g., intravenously, intramuscularly, or subcutaneously) to the patient.
Patent MX-2022016002-A (MX)
Title: Dna antibody constructs and method of using same.
Inventor: WEINER DAVID B
IPC: A61K31/7088
Filed: 2015-06-12
Abstract: Disclosed is a composition including a recombinant nucleic acid sequence that encodes an antibody. Also disclosed is a method of generating a synthetic antibody in a subject by administering the composition to the subject. The disclosure also provides a method of preventing and/or treating disease in a subject using said composition and method of generation.
Patent MX-2022016128-A (MX)
Title: Polyester carbonates having a defined proportion of ester groups.
Inventor: MEYER ALEXANDER
IPC: C08G63/199
Filed: 2021-06-11
Abstract: The present invention relates to a process for preparing a polyester carbonate on the basis of diacids and at least one 1,4:3,6-dianhydrohexitol and at least one additional cycloaliphatic dihydroxy compound, to a polyester carbonate and to a molding compound and a molding body containing the polyester carbonate. The polyester carbonates according to the invention are characterized by a high proportion of bio-based structural motives and good mechanical properties and molecular weights.
Patent MX-PA00003427-A (MX)
Title: Campylobacter vaccine.
Inventor: PETRUS JOHANNES MARIA NUIJTEN
IPC: C07K14/205
Filed: 2000-04-07
Abstract: The present invention relates to vaccines comprising antiserum raised against a flagellaless Campylobacter strain for the prevention of Campylobacter colonisation in animals. The invention also relates to antigenic Campylobacter proteins visible in a Western blot of Campylobacter jejuni protein after incubation of said Western blot with antibodies against a flagellaless mutant of Campylobacter jejuni and not visible after incubation of said blot with antibodies against wild type Campylobacter jejuni, and to their use in vaccines and the manufacturing thereof. The invention further relates to vaccines comprising such proteins and antibodies against such proteins. The invention further relates to the use of such Campylobacter proteins and to antiserum and antibodies raised against Campylobacter antigens for the preparation of vaccines. Finally, the invention relates to methods for the preparation of such vaccines.
Patent MX-PA01000369-A (MX)
Title: Utilization of derivatives of tetrahydropyridines (or 4-hydroxypiperidines)-butylazols in the preparation of a medicament for the treatment of pain.
Inventor: JORDI FRIGOLA-CONSTANSA
IPC: C07D401/06
Filed: 1999-07-09
Abstract: Derivatives of tetrahydropyridines (or 4-hydroxypiperidines)-butylazols of formula (I), wherein R1, R2 and R3, which are similar or different, represent each of them hydrogen, halogen, alkyl C1-C4, trifluoromethyl, hydroxyl, alkoxyl, or two adjacent radicals can form a ring; A is a C atom and the dotted line represents an additional bond, or A is a C atom joined to a hydroxyl group and the dotted line represents absence of additional bond; Z1 is N or CR4; Z2 is N or CR5; Z4 is N or CR7; and R4, R5, R6 and R7, which are similar or different, represent hydrogen, halogen, alkyl C1-C4, aryl or substituted aryl, or two adjacent radicals can form part of another ring. These derivatives are useful for the treatment of acute pain, neuropathic pain or nociceptive pain in mammals, including human beings.
Patent MX-PA01002307-A (MX)
Title: Fungicidal mixtures comprising r-metalaxyl.
Inventor: NUNINGER COSIMA
IPC: A01N37/44
Filed: 1999-09-02
Abstract: The present invention relates to novel fungicidal two-component compositions based on metalaxyl having an R-enantiomer content of more than 70% by weight as one essential component and a second fungicidal component, for the treatment of phytopathogenic diseases of crop plants, especially phytopathogenic fungi, and to a method of combating phytopathogenic diseases on crop plants. The metalaxyl component is called active ingredient (I). The following fungicides may be used as the second component (II) of the mixture: either a compound (IIA), N-(3'-(1'-chloro-3-methyl 2'-oxopentan))-3,5-dichloro-4-methylbenzamide (EP-600629); or a compound (IIB) (EP-253213) methyl (E)-2-methoxyimino-[2-(o-tolyloxymethyl)phenyl]acetate; or a (S)-valinamide of formula (IIC) (EP-472996); wherein R4 is isopropyl, and R5 is 4-methylphenyl, and wherein the asymmetric center is preferably (R); or a compound (IID) (EP-551048) (S)-1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one; or a compound (IIE), the Pseudomonas fluoresens strain, ATCC accesion No. 55169 (USP-5,348,742) is particularly effective incombating or preventing fungal diseases of crop plants. These combinations exhibit synergistic fungicidal activity.
Patent MX-PA02001591-A (MX)
Title: Enhancements for seams in on-machine-seamable papermaker's fabrics.
Inventor: GLENN J KORNETT
IPC: D21F7/10
Filed: 2002-02-14
Abstract: An on-machine-seamable papermaker's fabric, which may be produced by modified endless weaving, includes machine-direction (MD) and cross-machine-direction (CD) yarns. When so produced, the MD yarns weave continuously back and forth between the two widthwise edges of the fabric, each time forming a seaming loop at one of the two widthwise edges. Interwoven with at least one of the two sides, top and bottom, of the seaming loops at one or both widthwise edges are at least two additional CD yarns. The additional CD yarns interweave with the top and/or bottom of the seaming loops in a leno weave, which keeps the seaming loops in a common position vertically relative to the plane of the papermakers fabric, locks the seaming loops into a desired position and orientation with their planes perpendicular to that of the papermaker's fabric.
Patent MX-PA02002704-A (MX)
Title: Production of flexible polyurethane foams.
Inventor: JENS M LLER
IPC: C08G18/48
Filed: 2002-03-13
Abstract: The present invention relates to a process for the production of flexible polyurethane foams by reaction of a) at least one compound having at least two isocyanate-reactive hydrogen atoms, with b) polyisocyanates, wherein the compund used as said compound having at least two isocyanate-reactive hydrogen atoms a) comprises at least one block polyoxypropylene/ polyoxyethylene/ polyol having a hydroxyl value of from 25 to 45 mg KOH/g and a content of terminally bound ethylene oxide units of from 15 to 17 wt %, based on the total amount of the alkylene oxide, obtained by attachment of ethylene oxide and propylene oxide to an initiator having an average functionality of 3.
Patent MX-PA02003249-A (MX)
Title: Improved processing polyethylenes.
Inventor: PATRICIA METZGER COTTS
IPC: B29C48/32
Filed: 2000-09-28
Abstract: Polyethylenes made from ethylene and a series of agr; olefins using a catalyst that copolymerizes ethylenes and agr; olefins usually have excellent melt processing characteristics, especially in uses where high zero shear viscosity and low high shear viscosity are desirable. These polyethylenes are preferably made by forming the agr; olefins in situ from ethylene during the polymerization process. The polyethylenes are especially useful in blow molding, extrusion or extruded blown film processes.
Patent MX-PA02007028-A (MX)
Title: Copolymers and oil and water repellent compositions containing them.
Inventor: SOANE DAVID S
IPC: D06P1/653
Filed: 2000-09-08
Abstract: The present invention is directed to a copolymer capable of forming a water and oil repellent agent that enables binding to textiles and other materials without the production of formaldehyde. The copolymer according to the present invention comprises a) a fluoroaliphatic radical containing agent, (b) stearyl (meth)acrylate; (c) a chlorine containing compound; and (d) a monomer selected from those that contain an anhydride functional group or are capable of forming an anhydride functional group. The present invention further provides a water and oil repellency imparting composition for fibrous and other substrates, the composition comprising the above copolymer together with a catalyst, such as sodium hypophosphite, for forming anhydrides from the acid containing monomers in the copolymer. The composition can further optionally comprise other additives such as, for example, poly(acrylic acid); an extender, a softener; an antioxidant; a surfactant; and or a plasticizer.
Patent MX-PA02007467-A (MX)
Title: Method and apparatus for determining the internal impedance of a distribution transformer and sensing dc current through an ac power meter.
Inventor: SHUEY KENNETH C
IPC: G01R11/24
Filed: 2002-07-31
Abstract: A method for determining the DC current flowing through an AC power meter. The internal impedance of the distribution transformer is first sensed, then the DC voltage in the AC voltage waveform is measured and finally the measured DC voltage is converted to DC current.
Patent MX-PA02011985-A (MX)
Title: Glyoxal-phenolic condensates with enhanced fluorescence.
Inventor: GERBER ARTHUR H
IPC: C07B61/00
Filed: 2001-05-31
Abstract: Glyoxal-phenolic condensates, epoxidized products thereof, as well as their method of manufacture are disclosed. The condensates and epoxidized products have exceptionally high fluorescence as well as good ultraviolet absorbance. There is also disclosed compositions and laminates containing the condensates and epoxidized products thereof.
Patent MX-PA03000576-A (MX)
Title: Leucine-based motif and clostridial neurotoxins.
Inventor: AOKI KEI ROGER
IPC: A61P21/00
Filed: 2001-07-20
Abstract: Modified neurotoxin comprising neurotoxin including structural modification, wherein the structural modification alters the biological persistence, such as the biological half-life and/or a biological activity of the modified neurotoxin relative to an identical neurotoxin without the structural modification. In one embodiment, methods of making the modified neurotoxin include using recombinant techniques. In another embodiment, methods of using the modified neurotoxin to treat conditions include treating various disorders, neuromuscular aliments and pain.
Patent MX-PA03000967-A (MX)
Title: Apparatus for flushing a vascular catheter.
Inventor: ELLIS DONALD G
IPC: A61M25/00
Filed: 2000-08-01
Abstract: An apparatus for flushing a vascular catheter. Inlet and outlet passages extending from inlet and outlet ports, respectively, are selectably in communication with one another via a manually operable member cooperating with a sealing member and biased toward a closed position. Mechanisms for continuously and periodically flushing the catheter are incorporated.
Patent MX-PA03003057-A (MX)
Title: Cigarette filter and process for manufacturing the same.
Inventor: HORN SOENKE
IPC: A24D3/16
Filed: 2003-04-08
Abstract: Filter and process for producing filter for articles of the tobacco processing industry. The filter includes at least one filter component of multiple-component fibers. The multiple-component fibers have lengths shorter than a length of the filter. The process includes producing a rod including at least one type of multiple-component fibers having lengths shorter than a length of the filter to be produced. Further, the multiple-component fibers have a casing. The process further includes heating the rod to a temperature above a melting temperature of the casing, and cooling the rod to a temperature below the melting temperature of the casing. The instant abstract is neither intended to define the invention disclosed in this specification nor intended to limit the scope of the invention in any way.
Patent MX-PA03003482-A (MX)
Title: Treatment of sexual dysfunction.
Inventor: PINNOCK ROBERT DENHAM
IPC: A61P15/10
Filed: 2001-11-14
Abstract: Bombesin receptor antagonists have been found to be useful in the treatment of sexual dysfunction in both males and females. They may be selective BB1 antagonists or mixed BB1/BB2 antagonists. Combinations are disclosed of bombesin receptor antagonists with a range of other active compounds, for example PDE5 inhibitors, NEP inhibitors and lasofoxifene.
Patent MX-PA03010008-A (MX)
Title: Synthesis of lower alkylene oxides and lower alkylene glycols from lower alkanes and/or lower alkenes.
Inventor: STEPHEN WAYNE KING
IPC: C07C29/50
Filed: 2002-04-18
Abstract: A method and apparatus for synthesizing at least one of alkylene oxides and alkylene glycols from lower alkanes and/or lower alkenes. In the preferred embodiment, the apparatus included a lower alkane/alkene supply; an oxygen supply for providing a source of oxygen; and a metal oxide catalytic reactor. The metal oxide catalytic reactor included a reactor chamber; and a catalyst in the chamber for reacting the lower alkane/alkene supply with the source of oxygen to convert the lower alkane/alkene by selective partial oxidation to at least one of the alkylene oxides and alkylene glycols. Also, in the preferred embodiment, a separator, downstream form the reactor, separated the alkylene oxides and alkylene glycols from the total product stream and the unconverted reactants.
Patent MX-PA03010559-A (MX)
Title: Wide band voltage controlled crystal oscillator.
Inventor: CHANDRA MOHAN
IPC: H03B5/32
Filed: 2002-05-15
Abstract: A voltage controlled Colpitts type crystal oscillator includes a first crystal and a transistor coupled to the first crystal to provide positive feedback for generating an output oscillatory signal. A variable capacitance is coupled to the first crystal for producing a change in a frequency of the oscillatory signal when a corresponding change in the variable capacitance occurs. A first inductance is coupled in a resonant circuit that includes the variable capacitance and the first crystal having a value selected to provide a pulling range of at least 0.4% with respect to the frequency of the oscillatory signal. In one embodiment of the invention, a second crystal is coupled to the first crystal and included in the resonant circuit. An energy dissipating impedance is coupled in the resonant circuit to the first crystal for decreasing a Q characteristic of the first crystal to increase the pulling range of the oscillator. The first inductance separates the second crystal from each of the first crystal and the energy dissipating impedance to decrease an effect of the energy dissipating impedance on a Q characteristic of the second crystal.
Patent MX-PA03011312-A (MX)
Title: Plant and method for purification of water coming from a seulphuration kerosene plant.
Inventor: BRUNO CONTI
IPC: C02F1/68
Filed: 2001-06-08
Abstract: Method for purification of process water, in particular coming from a kerosene desulphuration plant, and related plant, comprising the steps of neutralising the process water, carrying out a washing of the process water by a solvent, and biologically treating the process water with bacteria apt to degrade pollutants (Fig.1).
Patent MX-PA04000870-A (MX)
Title: Use of lhrh-antagonists for the improvement of t-cell mediated immunity.
Inventor: MANFRED PEUKERT
IPC: A61K38/04
Filed: 2002-07-30
Abstract: The invention concerns the use of appropriate doses of an LHRH-antagonist to lower sex hormone levels resulting in a modification of the T-cell population in an individual suffering from a disease that will respond favourably to such modification. A preferred LHRH-antagonist is cetrorelix.